3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
7
Phase 4
1
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Neoplasms
3
Colorectal Neoplasms
3
Multiple Myeloma
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Polycythemia Vera
1
Parkinsonian Disorders
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Histiocytoma, Malignant Fibrous
1
High Grade Neuroendocrine Neoplasms
1
Interventions
Fluorouracil
87
Leucovorin
78
Oxaliplatin
77
Irinotecan
76
Bevacizumab
50
Cetuximab
42
Capecitabine
42
Panitumumab
17
Folfox protocol
16
Floxuridine
11
Chemotherapy, Adjuvant
11
regorafenib
10
IFL protocol
10
Nivolumab
9
Drug Therapy
9
trifluridine tipiracil drug combination
8
Surgical Procedures, Operative
8
Neoadjuvant Therapy
8
sargramostim
7
pembrolizumab
7
XELOX
7
Specimen Handling
7
Biopsy
7
Trastuzumab
6
Radiotherapy
6
Magnetic Resonance Spectroscopy
6
HMPL-013
6
tislelizumab
5
encorafenib
5
Trifluridine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Colonic Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT06425133
2024-12-24
CARE
Centre Hospitalier Universitaire de Besancon
Phase 2
Recruiting
174 enrolled